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Feedback activation in rat nephrons by sera from patients with
acute renal failure. Tubuloglomerular feedback (TGF) may be
triggered by varying the distal electrolyte load. TGF may con-
tribute to acute renal failure (ARF), but maximal TGF stimula-
tion induces only relatively small alterations in single nephron
GFR (SNGFR) and stop-flow pressure (SFP), whereas in ARF,
GFR may cease, raising the possibility that substances eliciting
greater TGF responses than do elelectrolytes occur in ARF. We
have sought such substances in serum, urine, and peritoneal fluid
from patients with ARF. Sera samples from I healthy subject, 4
ARF patients, and 2 other anuric patients were dialyzed against
glucose to reduce electrolyte concentrations and perfused
through Henle's loops in salt-deplete rats. With ARF sera, SFP
fell from 35.6 (SD) 3.5 to 20.9 3.4 mm Hg (P < 0.005) and
SNGFR from 28.5 8.7 to 12.6 7.3 nllmin (P < 0.005). Fur-
osemide (10-i M) did not abolish the response. Perfusion with
other patients' sera had no effect on SFP. ARF urine or perito-
neal fluid induced similar responses. Conclusion. In some ARF
patients, substances present in serum activate TGF in the rat.
These substances might contribute to development of certain
forms of human ARF, particularly ARF associated with liver
dysfunction (hepatorenal syndrome).
Activation du feedback dans les néphrons de rat par le serum de
malades atteints d'insufiisance rénale aigue. Le feedback tubulo-
glomerulaire (TGF) peut être déclenché par une modification de
Ia charge d'électrolytes au distal. TGF peut contribuer a I'm-
suffisance rénale aiguC (ARF), mais la stimulation maximale de
TGF ne determine que des modifications relativement faibles des
filtrations glomCrulaires individuelles (SNGFR) et de Ia pression
de stop flow (SFP), alors qu'au cours de l'insuffisance rénale
aiguC Ia filtration glomérulaire cesse. Cela suggère que des sub-
stances autres que des electrolytes, determinant une réponse de
TGF plus importante, puissent exister au cours de l'ARF. Nous
avons cherché de telles substances dans le serum, l'urine et le
liquide péritonéal de malades atteints d'ARF. Les serums d'un
sujet normal, de quatre malades atteints d'ARF et de deux autres
malades anuriques ont été dialyses contre du glucose afin de ré-
duire les concentrations electrolytiques, puis perfusés dans des
anses de Henle de rats déplétés en sel. Avec du serum d'ARF,
SFPadiminuéde35,6 3,4 mm Hg (P <0,005)
et SNGFR de 28,5 8,7 a 12, 6 7,3 nI/mm (P < 0,005). Le
furosémide (10-i M) n'a pas aboli Ia réponse. La perfusion avec
du serum d'autres malades n'a pas eu d'effet sur SFP. L'urine et
le liquide péritonéal de malades atteints d'ARF ont déterminé
des responses semblables a celles obtenues avec le serum. II est
conclu que chez certains malades atteints d'ARF il existe dans le
serum des sl4bstances qui peuvent activer TGF chez le rat. Ces
substances peuvent contribuer au développement de certaines
formes d'ARF, particulièrement des ARF associées a un dys-
fonctionnement hépatique (syndrome hépato-rénal).
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In 1937, Goormaghtigh [1] suggested that, in view
of the intimate contact between the macula densa
and the vascular pole of the glomerulus, the jux-
taglomerular apparatus might be involved in the
pathogenesis of acute renal failure (ARF). The exis-
tence of a functional relationship between these ele-
ments was first demonstrated by Thurau and
Schnermann [2], who observed proximal tubular
collapse in nephrons in which the macula densa re-
gion was perfused from the distal tubule with iso-
tonic saline. This has been amply confirmed since
(for review, see Ref. 3). The clarification of this
tubuloglomerular feedback mechanism has led a
number of authors to reexamine the possibility that
this mechanism might be involved in the pathogene-
sis of ARF [4-7]. The hypothesis is, briefly, that im-
paired tubular electrolyte transport proximal to the
macula densa leads to an increase in distal elec-
trolyte load, a stimulus known to trigger the feed-
back response reducing GFR [3, 7]. Evidence has
been obtained in both nephrotoxic and ischemic
models of ARF that transport proximal to the mac-
ula densa is impaired [3, 6], that distal electrolyte
load is increased [4-6], and that the feedback mech-
anism remains functional under these circum-
stances [4—6].
It is, however, interesting to note that experimen-
tal studies on the feedback mechanism have shown
that maximal stimulation is unable to reduce neph-
ron filtration rate by more than approximately 50%,
whereas GFR seems to fall practically to zero in
certain forms of ARF. This raises the possibility
that, if the tubuloglomerular feedback mechanism is
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involved in ARF, then it may be triggered by sub-
stances other than electrolytes and capable of pro-
ducing a greater response. This possibility is exam-
ined in the present study by measuring proximal
tubular stop flow pressure (SFP) as an indirect mea-
sure of glomerular capillary pressure, nephron fil-
tration rate (SNGFR), and early proximal tubular
flow rate (EPFR) during perfusion of the early distal
tubule of rat nephrons with sera, urine, and perito-
neal fluid, dialyzed against glucose to remove elec-
trolytes, from a healthy subject, from patients with
ARF, and from patients anuric due to other causes.
Methods
Perfusion fluids. Serum, urine and peritoneal
fluids were variously obtained from the following
subjects who, with the exception of control subject
0, were anuric or oliguric due to acute renal failure
(I, II, III, and VI), cardiovascular shock (IV), or
chronic renal failure (V).
Serum 0 and urine 0 were obtained from a 35-
year-old male with no known illness, and not taking
any medication.
Serum I was obtained from a 22-year-old female
with aspergillus septicemia. Blood pressure on ad-
mission was not measurable but shortly thereafter
was found to be 110/30 mm Hg. There were repeat-
ed episodes of pulmonary edema. The serum
sample was obtained 3 days after admission, when
her blood pressure was 110/30 mm Hg and her urine
flow was 36 ml/day. Her serum creatinine had risen
from 0.9 to 5 mg/dl. At autopsy the following were
observed: aspergillus septicemia, bicuspid aortic
valve, massive liver necrosis, and disseminated in-
travascular coagulation. Renal histology was essen-
tially normal.
Serum, urine, and peritoneal fluid II were ob-
tained from a 57-year-old man who, after vagotomy
and pyloroplasty, required artificial respiration due
to bilateral pneumonia. Escherichia coil and
Pseudomonas aeruginosa were present in his blood
cultures. He had a previous history of alcoholic
liver cirrhosis. On admission, his renal function was
essentially normal, with a serum creatinine concen-
tration of 0.9 mgldl and blood urea concentration of
40 mg/dl. Endogenous creatinine clearance was 140
mllmin. After establishment of septicemia, his renal
function progressively deteriorated. Creatinine
clearance was 85 ml/min on day 4, 15 mi/mm on day
7, and by day 10, oliguria/anuria was present. At
that time his serum creatinine concentration was 7
mg/dl, and his urea concentration was 330 mg/dl.
The mean blood pressure in his femoral artery re-
mained at 70 to 80 mm Hg over this period, with no
prolonged hypotensive periods. Serum samples
were taken on day 3 (creatinine clearance, normal);
day 5, creatinine clearance was 85 mI/mm; day 7,
creatinine clearance was 15 mI/mm), and on day 10
he was anuric. Urine and peritoneal fluid samples
were also obtained on day 10. At autopsy, his kid-
neys showed focal interstitial nephritis; his liver
was reduced in size and showed micronodular cir-
rhosis; he had had a right cerebellar hemorrhage
and severe bilateral pneumonia.
Sera III were obtained from a 60-year-old man
suffering from exposure and frost bite to both feet.
On admission, his blood pressure was unmeasur-
able and had been for several hours, but after vol-
ume expansion and corticosteroid administration it
returned to normal within an hour. Disseminated in-
travascular coagulation and a bilateral bron-
chopneumonia were also found on admission. Co-
agulation factors were found to be abnormally low,
and thrombocytopenia was present. The first serum
sample was obtained on day 2. His serum creatinine
concentration was 9 mg/dl, his urea concentration
was 269 mg/dl, and his urine flow was 324 ml/day.
On day 4, the second sample was obtained, and his
endogenous creatinine clearance was 7.2 mL'min.
His creatinine clearance rose to 18 mi/mm by day 12
and 20 mI/mm by day 15; samples were taken on
both these days.
Serum IV was obtained from a 68-year-old male
with extensive infarction of the posterior myo-
cardium. His mean arterial blood pressure was 40
mm Hg. The serum sample was obtained 14 hours
after the infarct when he had been anuric for 4
hours.
Serum V was obtained from a 45-year-old male
with chronic renal failure due to analgesic nephrop-
athy. He had been on hemodialysis for 2 years. One
serum sample was obtained when his blood pres-
sure was 105/70 mm Hg and his urine flow was 300
mi/day.
Serum VI was obtained from a 56-year-old wom-
an. She was very obese and had a history of recur-
ring cholangitis. Diabetes mellitus had been diag-
nosed 6 years earlier. Prior to admission, she had
been taking a tranquilizer (diazepam) and a diuretic
(furosemide) in unknown doses. She had not re-
ceived any oral antidiabetics. She was admitted for
weakness and anorexia, and suddenly developed
acute liver dystrophy and a lactate acidosis. She be-
came anuric, with a blood pressure of 110/70 mm
Hg. The serum sample was obtained after 3 hours of
anuria. Serum analysis revealed the following con-
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centrations: creatinine, 2.5 mg/dl; urea, 110 mg/dl;
glucose, 150 mgldl; pH, 7.19; base excess, more
than 25 mEq/liter; lactate, 16 mmoles/liter; biliru-
bin, 6.9 mg/dl; SGOT, 104 U/liter; SGPT, 102 U/
liter; cholinesterase, 1000 U/liter; prothrombin
time, 27 sec (normal, 13 to 16 sec). At autopsy, a
large yellow liver (3100 g) was found, macroscopic-
ally the kidneys appeared normal, and histology
showed slight to medium arteriosclerosis.
Perfusate preparation. Samples of serum, urine,
or peritoneal fluid were centrifuged at 4000 rpm for
5 mm at 4° C. Aliquots (10 ml each) were then dia-
lyzed through Cuprophan tubing (mean pore size,
3.1 nm) against 140 m glucose for 12 hours at 2° C.
The serum volume doubled due to the dialysis
against a colloid-free solution. Serum sodium con-
centration fell to 7 mEq/liter, chloride concentra-
tion fell to less than 1 mEq/liter, and osmolarity was
the same in the dialyzed serum sample as it was in
the dialysate. The dialyzed serum protein concen-
tration was reduced to half, corresponding to the
dilution. The concentrations of nonelectrolytes
measured after dialysis corresponded to those
found by Bottomley. Parsons, and Broughton [8].
Micrope,jision experiments. Experiments were
carried out in female Wistar rats, each weighing 180
to 250 g, which had been maintained on a low-salt
diet (1 mEq/day/kg body wt) for 3 to 4 weeks. Anes-
thesia was induced by the i.p. injection of sodium
thiopental (80 mg/kg body wt; Trapanal®, Promonta,
Hamburg), and body temperature was kept con-
stant at 3750 C by a feedback controlled heating
pad. All animals received a sustaining infusion con-
taining sodium chloride, 75 mEq/liter; glucose, 140
mM; and polyfructosan (mutest Laevosan, Linz),
125 g/liter. This solution was infused i.v. at a con-
stant rate between 0.26 and 0.34 mi/hr/kg. Arterial
blood pressure was monitored continuously with a
strain-gauge pressure transducer (Statham) con-
nected to an electromanometer (Hellige) and re-
corder (Rikadenki). At the conclusion of each ex-
periment, arterial blood gas analysis was per-
formed. Experimental results from animals with an
arterial oxygen tension of less than 70 mm Hg and a
calculated base excess of —6 mEq/liter were dis-
carded. This amounted to three rats over the whole
project.
The left kidney was exposed through a flank in-
cision and prepared for micropuncture [9]. Micro-
puncture was commenced some 2 hours after the
induction of anesthesia. Stop-flow pressure (SFP) in
the proximal tubule was measured in the following
manner during perfusion of the loop of Henle and
early distal tubule from the last accessible proximal
tubular segment (orthograde perfusion): Free-flow
pressure in a proximal segment was measured with
either a servo-nulling micropressure system [10] or
microtransducer [11]. High viscosity (30,000 cP)
silicon oil (Wacker, Munich) was then injected from
a micropipette (tip diameter, 15 m) into the proxi-
mal tubule downstream from the pressure pipette.
As soon as the pressure in the blocked tubule
reached a constant level (SFP at zero perfusion),
another pipette (tip diameter, 6 to 8 /Lm) containing
the perfusion solution and connected to a micro-
perfusion pump (Hampel, Frankfurt) was inserted
distal to the oil block into the last accessible proxi-
mal segment, and perfusion was commenced at 20
ni/mm, or, in the case of some sodium chloride per-
fusions, at 30 ni/mm. The perfusion pump was a vol-
ume-displacement type with a feedback controlled
motor. At a set value of 20 nl/min, it delivered 18.5
to 24 ni/mm, similar to the results of Wright and
Schnermann [12]. Possible sources of variation in-
clude temperature effects [11] as well as leaking
seals or motor irregularity. Because satisfactory
thermal insulation of the perfusion pipette was diffi-
cult, the pipette was removed from the tubule to
achieve zero flow. In some experiments, SFP and
SNGFR were measured during retrograde perfusion
of the loop of Henle from the first accessible distal
segment, the perfusate being collected from the
proximal tubule distal to the oil block. Normal oper-
ation of the feedback mechanism was tested with
sodium chloride perfusion with and without furo-
semide (10 M).
In another series of experiments, single nephron
filtration rate (SNGFR) and early proximal tubular
flow rate (EPFR) was measured during perfusion of
the loop of Henle with ARF sera, urine, peritoneal
fluid, control serum, and urine with Ringer's solu-
tion. This was done in the standard manner [9].
Considerable difficulty was experienced in the col-
lection of the very small volumes during low
SNGFR. Under these conditions, the pipette's ca-
pillarity was sufficient to make the tubule collapse.
Given the difficulty in collecting sample volumes
large enough for accurate inulin analysis, in some
experiments only the proximal tubular flow rate was
measured. When this was done, collections were
made from as early a proximal segment as possible
under which conditions early proximal flow rate
(EPFR) might be considered as approximately
equivalent to SNGFR. Tubular fluid volumes were
measured by the method of Ulfendahl [13], modi-
fied by using a water-saturated, paraffin-oil, high-
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viscosity-immersion oil mixture. The fluid droplets
were introduced into this oil and remained for less
than 20 sec while the diameter was measured. There
was no visible decrease in sample droplet diameter
during this period.
Inulin concentation in tubular fluid was measured
by the method of Hilger, Klümper, and Ullrich [14],
using a l-tl cuvette [15] and in plasma and urine by
the method of Führ, Kaczmarczyk, and KrUttgen
[16]. SNGFR was calculated by multiplying tubular
flow rate by the tubular fluid to plasma inulin con-
centration ratio. The GFR of the left kidney was
measured like the inulin clearance. Student's t test
was used to assess the significance of differences in
mean values, for paired samples where appropriate
[17].
Results
Perfusion with sodium chloride, wit/i and without
furosemide. The results summarized in Table 1 show
that perfusion of the loop of Henle with sodium
chloride reduced the stop-flow pressure (SFP) in
that nephron. Addition of furosemide (l0- M) abol-
ished this effect. In 14 tubular perfusions in 2 rats,
the mean SFP at zero perfusion was 36.2 2.7
mm Hg. This fell significantly to 33.2 3.2 mm Hg
at a perfusion rate of 30 nllmin (P < 0.05) and rose
to 35,8 2.5 mm Hg when perfusion ceased. Per-
fusion at 20 nl/min' was insufficient to cause a sig-
nificant fall in SFP. Addition of l0 M furosemide
to the perfusion solution abolished the effect on
SFP of increasing perfusion rate.
Measurements of single nephron filtration rate
(SNGFR) during 6 loop of Henle perfusions with
Ringer's solution in 2 rats are presented in Table
2 and Fig. 2A. At zero perfusion, SNGFR was 32.0
8.4 nl/min, and this fell significantly to 22.2
11.1 nI/mm (P < 0.025) at a perfusion rate of 40 nIl
mm. The proximal tubular fluid flow rate fell under
these conditions from 28.2 4.3 to 14.2 7.9 nIl
mm (P < 0.025), and the TF/P111 rose from 1.28
0.1 to 1.53 0.13 (P < 0.05).
Perfusion with sera from patients: (I) Stop-flow
pressure. Before beginning perfusions with sera
from patients, 1 or 2 tubules were perfused with
isotonic sodium chloride as a control. Those re-
sults are not separately presented but are included
in Table 1 under sodium chloride perfusions.
Orthograde loop of Henle perfusion at 20 nl/min
with serum 1(7 tubules in 4 rats) resulted in a signifi-
cant fall in SFP, from 35.1 3.2 to 20.3 4.1 mm
Hg (P < 0.005). Retrograde perfusion with the
same serum (6 tubules in 4 rats) resulted in a signifi-
cant fall in SFP, from 37.3 2.4 to 13.1 2.3 mm
Hg (P < 0.005). Fig. 1 is a recording of proximal
tubular pressure from an experiment in these series.
Essentially similar results were seen in a total of 14
further perfusions with sera II and III (table 1). Ad-
dition of 10 M furosemide to serum I did not abol-
ish the response. Perfusion with control serum 0 (7
tubules in 2 rats), serum IV (5 tubules in 1 rat), and
serum V (7 tubules in 2 rats) had no significant ef-
fect on SFP.
(2) Single nephron glomerular filtration rate
(SNGFR). Nephron filtration rates were measured
Table 1. Response in proximal tubular stop-flow pressure to perfusion of the early distal tubule with a range of substancesa
N
Stop-flow pressure, mm Hg
AtO At20 At30 AtO
Perfusion solution (tubules/rats) nlmin' nlmin' nlmin' nlmin'
Control solutions
150mM NaCI (14/2) 36.2 2.7 35.4 3.0 33.2 3.2b 35.8 2.5
150 mM NaCI + 104M furosemide (4/1) 40.6 2.1 39.8 3.3 39.5 2.7
Acute renal failure sera
Serum florthograde perfusion) (7/4) 35.1 3.2 20.34 4.1c 34.6 2.0
Seruml(retrograde perfusion) (6/4) 37.3 2.4 18.1 2.3' — 36.8 2.9
Serum II (day 10) (6/2) 32.2 3.3 19.5 2.3'
Serum III (8/3) 37.0 2.8 23.7 2.lc 36.2 1.9
Means (ARF sera) 35.6 3.5 20.9 3.4' — 35.5 3.6
Serum I + 104Mfurosemide (4/1) 33.2 4.8 18.5 1.5' — 31.8 2.8
Other sera
Serum 0 (7/2) 38.4 3.0 38.7 8.1 — 38.0 1.4
Serum IV (5/1) 39.2 2.4 38.9 4.0 — 40.1 3.2
Serum V (7/2) 35.6 2.9 37.1 3.2 — 38.2 2.6
Drug mixture (4/2) 36.4 1.1 37.8 1.9 .— 35.2 1.7
a Values are the means so.
b P < 0.005, compared to first control period.
P < 0.005, compared to first control period.
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during loop perfusion with sera I (17 tubules in 4
rats) and VI (7 tubules in 1 rat). These results are
presented in Fig. 2 and are summarized in Table 2.
During orthograde perfusion with serum I (Fig. 2B),
SNGFR fell significantly from 29.1 7.9 nllmin at
zero perfusion to 10.4 5.0 nllmin at a perfusion
rate of 20 nllmin (P < 0.005) and rose to 27.8 8.7
nl/min after perfusion ceased. On retrograde per-
fusion with serum I, SNGFR fell from 29.6 5.0 nh
mm at zero perfusion to 14.5 8.1 nl/min at a per-
fusion rate of 20 nI/mm (P < 0.005) and rose to 26.5
8.7 nl/min after perfusion ceased (Fig. 2C).
Orthograde perfusion with serum VI resulted in a
fall in SNGFR from 26.4 13.0 nl/min at zero per-
fusion to 13.3 8.9 nllmin (P < 0.005) at a per-
fusion rate of 20 nh/min. After perfusion ceased,
SNGFR rose again to 22.2 7.7 nh/min (Fig. 2D).
We frequently observed that SNGFR appeared to
decrease progressively during perfusion, and in one
case we were able to collect serial proximal samples
from such a tubule during a perfusion. This is illus-
trated by the dotted line in Figure 2B. On perfusion,
SNGFR fell in this tubule to 24, then to 11, and fi-
nally to 3 nI/mm.
Under these conditions, sample volumes became
extremely small. In some cases the amount of fluid
sufficed only for volume determination and not for
inulin analysis. Where inuhin analysis was just pos-
sible, duplicates showed considerable scatter. The
proximal TF/P inulin during perfusion with serum
I rose from 1.18 0.07 during zero perfusion
to 1.25 0.10 during perfusion at 20 nlmin1
and afterwards fell to 1.12 0.08. During perfusion
with serum VI, the TF/P inulin fell from 1.82 to 1.67
during perfusion and further to 1.30 after perfusion
ceased. These TF/P inulin differences result partial-
ly from the fact that serial collections in a single tu-
bule require that the puncture site become progres-
sively more proximal to avoid leaks at the puncture
site.
(3) Early proximal flow rate (EPFR). With the dif-
ficulties in obtaining sufficient sample volumes at
low flow rates for accurate inulin analysis, we de-
cided to measure only EPFR during perfusion of the
loop of Henle with those remaining sera samples
that produced falls in SFP. These results are pre-
sented in Figs. 3 to 5. Perfusion with serum II,
taken on day 3 when renal function was normal, had
no effect on EPFR (Fig. 3A), whereas the sample
from day 5, when the creatinine clearance was 85
mI/mm, induced a fall of some 28% in EPFR, from
27.2 to 20.0 nhlmin (P <0.05) (Fig. 3B). The sample
taken on day 7, when creatinine clearance was 15
ml/min, induced a fall of 37% in EPFR, from 28.8 to
18.2 nhlmin (P <0.05) (Fig. 3C); and that on day 10,
when creatinine clearance was less than 3 mI/mm,
induced a fall of 80%, from 32.7 to 6.7 nl/min (P <
0.005) (Fig. 3D). Urine and peritoneal fluid II, also
Table 2. Responses in early proximal tubular flow rate (EPFR), tubular fluid to plasma inulin concentration ratio (TF/P1), and single
nephron glomerular filtration rate (SNGFR) to loop of Henle perfusion with acute renal failure serum or Ringer's solutiona
N
(tubulesl
EPFR, nl,nin TF/P1,, SNGFR, nImin'
At0 At20 At40 AtO AtO At20 At40 AtO AtO At20 At40 AtO
Perfusate rats) nlmin nlmin' nl•min' nlmin' nlmin1 nl•min nlmin1 nlmin' nlmin' nlmin' nlmin' nlmin'
Ringer's solution
p
(6/2) 28.2 14.2
L_ <0.025—
1.28 1.53
L_ <oo5—
32.0 22.2
1—_ <O.O25—
ARF sera
Serum I
(orthograde 9/3,
retrograde 8/3) (17/4) 25.1 8.9 23.9 1.18 1.25 1.12 29.8 12.0 27.4
p L<0001J L<00Ø1___J
NS
L<O05JL_<OJl
NS
i
'
L<000liL__<000l__.J
NS
Serum VI (7/1) 15.8 8.0 17.0 1.82 1.67 1.30 26.4 13.3 22.2
p L<00lJL<0t13l
I NS
'—NS--11--—<0.0l
NS
I
'
L<005JL<0Øij1__J
NS
Means(ARFsera) 22.4 8.6 21.9 1.37 1.37 1.17 28.5 12.6 25.7
p L<01iL<0J1J
I NS
L_NS_1t<0.001
I <0.05
I
I
L<O.liL<0.O0lJ
NS I
a Values are the means SD. The significance of differences between control and perfusion periods are indicated by the brackets.
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Oil I I
+ Furosemide
Free Stopflow flow
Fig. 1. Pressure recording with free-flow pressure in proximal
tubules rising to stop-flow pressure while oil is injected. Perfus-
ing the ioop of Henle with deionized serum of patient with ARF
results in a fall of stop-flow pressure, which cannot be blocked
by furosemide.
taken on day 10, induced falls of 72% (from 28.3 to
8.0 nllmin.P <0.005) and 53% (from 23.7 to 11.2 nIl
mm, P <0.05) in EPFR, respectively (Fig. 4, B and
C). Serum and urine samples from a healthy volun-
teer had no effect on EPFR (Fig. 4, D and E).
Whereas the above series used sera from a pa-
tient with progressively deteriorating renal func-
tion, the renal function of patient III improved pro-
gressively. Serum drawn on day 2 from this patient
(creatinine clearance, less than 2 mllmin) induced
an 80% fall in EPFR, from 27.8 to 5.6 nllmin (P <
0.005) (Fig. 5A), when perfused through the loop of
Henle at 20 nllmin, whereas that taken on day 4
(creatinine clearance, 7 mllmin) induced a fall from
27.8 to 14.3 nllmin, some 49% (P <0.005) (Fig. SB).
Serum taken on day 12 (creatinine clearance, 18 mu
mm) had very little effect, as did that taken on day
15 (creatinine clearance, 20 mI/mm) Fig. 5, C and D.
Perfusion with other test solutions. Solutions of
gentamicin, cephalosporin, digoxin, and furose-
mide, medications that may have been present in
the patient's sera, as well as glucose and human
serum albumin, were perfused into the loop of
Henle (4 tubules in 2 rats), and SFP was measured.
Mean values for SFP during perfusion of a mixture
of these substances are presented in Table 1; there
was no significant effect.
Discussion
Perfusion of the loop of Henle and early distal tu-
bule with sera, urine, and peritoneal fluid obtained
from patients with acute renal failure (ARF) result-
ed in a large fall in SFP, proximal flow rate, and
SNGFR of the perfused nephron. Electrolyte con-
centrations in these fluids had been reduced by dial-
ysis to values much lower than those normally en-
countered in the rat distal tubule [6, 18]. Such re-
sponses were not observed with serum or urine
from a normal subject or with serum from a patient
with prerenal failure or from a patient with chronic
renal failure. Perfusion of this tubular segment with
sodium chloride also induced a fall in SFP of some 3
mm Hg, which is consistent with the findings of
Wright and Schnermann [12] who found a fall of 4.6
mm Hg when perfusing at 40 nllmin. The small dif-
ference may be accounted for by minor differences
in protocol and the different strain and sex of rats
used in the present study. Also consistent with
these authors was our finding that furosemide abol-
ished the response in SFP to sodium chloride per-
fusion. In contrast, addition of furosemide to serum
I did not abolish its effect on SFP.
In contrast to the modest fall in SFP with sodium
chloride perfusion at 30 mllmin, perfusion with the
effective sera at only 20 nllmin resulted in a much
greater fall in SFP, from about 36 mm Hg to about
20 mm Hg, which, according to the current view of
glomerular dynamics [19], ought to reduce filtration
considerably. Indeed, in one perfusion, SNGFR
was seen to fall progressively from 24 to 3 nllmin.
The mean fall in SNGFR, however, was only to
43% of control. The explanation for this is most
likely technical. Reliable and quantitative collec-
tions of tubular fluid in amounts adequate for analy-
sis were not possible during large reductions in
SNGFR; thus, the mean value would have been
gained from those nephrons in which the fall in
SNGFR was least. Measurement of SFP, on the
other hand, is technically simpler and more reliable,
and thus it is likely that the large fall in SFP during
lengthy perfusions with the effective sera does in-
deed represent nearly complete cessation of filtra-
tion.
To explain falls in SNGFR and SFP, some altera-
tion in glomerular dynamics must be sought. Possi-
bilities are a decreased effective filtration pressure,
due to either afferent artenolar vasoconstriction, or
efferent dilatation, or a fall in hydraulic con-
ductivity. The latter alone is unlikely to explain a
fall in SFP, although it might contribute to the de-
creased SNGFR [20]. Efferent arteriolar dilatation
can be excluded because this would decrease renal
vascular resistance, a mechanism inconsistent with
the commonly observed reduction in renal blood
flow in ARF. Thus, afferent arteriolar vasoconstric-
tion remains the best alternative, although a pos-
sible contribution from a decreased hydraulic con-
ductivity can not be excluded.
This response in SFP, SNGFR, and proximal
flow rate to some early distal "signal" corresponds
to that observed by Schnermann, Nagel, and
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Fig. 3. Response of early proximal flow rate to perfusion of the
loop of Hen/c with serum samples from patient! taken on days 3,
5, 7, and 10 after admission. Overall renal function is indicated
by the creatinine clearance (Ccr). Means so are given. The
mean difference between the control and the perfusion period
is given by d. < 0.05; ** < 0.005.
fusion rates, at which there is no significant effect of
sodium chloride or Ringer's solution, and indeed
seems to increase even further with prolonged per-
fusion; and second, the stimulus must be somewhat
0 20
D 32.7 6.7 5.7
Fig. 2. Response of nephron filtration rate to perfusion of the
loop of Henle with Ringer's solution (A) or serum I in either
orthograde or retrograde directions (B or C), or serum IV (D).
Parentheses enclose the number of tubular perfusions with the
number of rats in each group. Means so are given. In each
case, the mean difference (sd) between the initial control period
and the perfusion period, expressed also as a percentage is indi-
cated by I; and the mean difference between the perfusion period
and the second control period, by II. <0.05; < 0.005.
Thurau [18], in particular in rats on a low-salt diet
[21]. In these studies, the response was also trig-
gered by some early distal signal, and the proposed
preglomerular vasoconstriction was found to be re-
versible on cessation of perfusion. On the other
hand, in our study there are two important dif-
ferences: first, the response is greater at low per-
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Means SD are given; zd is the mean difference between the
control period and the perfusion period.
different because the sera contained practically no
electrolyte. Doubtlessly, an electrolyte will diffuse
into the perfusate on its passage through the loop of
Henle, but this must happen equally for the active
and nonactive sera. Furthermore, if the response
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were due in some manner to the electrolyte, it
would be expected that furosemide would interfere
with that response, as was the case for perfusion
with sodium chloride, both here and in the studies
of Wright and Schnermann [12]. When added to one
of the active sera, however, furosemide did not af-
fect the response.
An interesting possibility was recently raised by
Navar et al [22]. They reported that perfusion of the
dog nephron from late proximal to early distal with
nonelectrolyte solutions (mannitol, glucose, and
urea) also elicited feedback responses, thus sug-
gesting that variations in tubular fluid osmolality or
solute load may be involved in the trigger mecha-
nism. The following observations are pertinent to
that conclusion: first, for technical reasons, they
were unable to analyze early distal tubular fluid to
determine the extent to which electrolyte entered
the loop of Henle; second, that such electrolyte en-
try would presumably be greatest at low flow rates
and with the highest concentrations of non-
reabsorbable solute, the conditions under which the
responses were found; and third, that these re-
sponses were abolished by furosemide. These con-
siderations lead to the conclusion that the responses
observed by these authors were indeed electrolyte-
mediated and that there is little evidence for a non-
specific osmotic mechanism. In any case, in our
study, the fact that, although all perfusates had the
same osmolality, some were able to elicit a feed-
back response whereas some could not, and that
such response was not affected by furosemide,
would seem to eliminate the possibility of either an
electrolyte or nonspecific osmotic trigger mecha-
nism being responsible.
Thus, a different stimulus must be sought: a sub-
stance or substances, presumably, that appear in
the blood, pentoneal fluid, and urine in certain path-
ologic states and that induce a fall in SFP and
SNGFR via the macula densa, although a direct ef-
fect on glomerular arterioles cannot be excluded.
We are not able to draw any exact conclusions as to
the nature of these substances.
They are clearly not freely dialyzable through the
Cuprophan dialysis membrane, which suggests that
the molecular weight exceeds 1000 at least, but
more probably 4000 to 6000 daltons [8]. Such a size
is compatible with endotoxins [23] or intracellular
polypeptides.
Under normal physiologic circumstances, solutes
with molecular weights below 70,000 daltons may
be expected to pass the glomerular barrier [24], al-
though in this case an even greater permeability
may be expected, because all the patients had some
degree of proteinuria. In fact, urine from patient II
(dialyzed in the same manner as the sera, and hence
without electrolytes) was also seen to induce a fall
in early proximal tubular flow rate, whereas similar-
ly treated urine from a healthy volunteer had no
such effect. Furthermore, the presence of such a
substance in the peritoneal fluid would be expected
if it were demonstrable in both serum and urine.
This too seems to be the case. Thus, it is quite fea-
sible that such substances would be filtrable and
could reach the macula densa.
It may be argued that the medication received by
these patients might have been responsible for the
observed response. A range of these, however,
both individually and as a mixture, failed to elicit
the response when perfused into the early distal tu-
bule. Furthermore, although a number of metabo-
lites and other substances accumulate in and may
be isolated from the sera of patients with chronic
renal failure [25], the dialyzed serum of one such
patient was also ineffective in inducing the re-
sponse, as was serum from an anuric patient with
prerenal failure due to cardiogenic shock.
The small number of subjects in the present study
does not permit any generalizations as to the origins
and occurrence of substances affecting the tubulo-
glomerular feedback mechanism. One possibility is,
however, suggested by the observation that, despite
selection of patients purely on the basis of ARF, the
active sera samples were obtained from patients in
whom severe liver dysfunction was present. At au-
topsy, patient I had massive liver necrosis, patient
II had a history of cirrhosis, and patients III and VI
had diagnosed liver dysfunction. Hepatic in-
volvement in certain forms of ARF is also suggested
by the observation that transplantation of a healthy
liver into an anuric patient resulted in restored urine
flow [26], as did transplantation of the kidney from
such a patient into a normal recipient [27]. Further-
more, the decline in the activity of this substance in
the serum of patient III over the 13 days in which
renal function was recovering, and the rise in activi-
ty in the serum of patient II over the 7 days in which
his renal function was deteriorating suggest that
such a substance may have clinical relevance in the
genesis and maintenance of this form of ARF.
Thus, although we are tempted to speculate that
the substances in question are released or not cleared
by the liver in certain pathologic states, thus pro-
viding a possible explanation for the finding that
certain types of liver dysfunction are associated
with ARF, we must await both the identification of
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the substance(s) and a broader examination of its
occurrence before we make any firm interpretation
of these findings.
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